Dechra Patents – Key Insights and Stats

Dechra has a total of 147 patents globally, out of which 63 have been granted. Of these 147 patents, more than 46% patents are active. The United States of America is where Dechra has filed the maximum number of patents, followed by Europe and Brazil. Parallelly, the United States of America seems to be the main focused R&D centre and also United Kingdom is the origin country of Dechra.

Dechra was founded in the year 1997. Dechra is a global pharmaceutical company with a veterinary market focus. Its primary area of expertise is the creation and promotion of medications for companion animals. The business is divided into four segments: services, US pharmaceuticals, European pharmaceuticals, and US pharmaceuticals. As of February 2023, Dechra Pharmaceuticals has a market cap of $4.29 Billion.

Do read about some of the most popular patents of Dechra which have been covered by us in this article and also you can find Dechra patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Dechra patent portfolio.

How many patents does the CEO of Dechra have?

The CEO Ian Page have 0 patents.

How many patents does Dechra have?

Dechra has a total of 147 patents globally. These patents belong to 45 unique patent families. Out of 147 patents, 68 patents are active.How Many Patents did Dechra File Every Year?

Dechra Patents Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantDechra Applications FiledDechra Patents Granted
20221
2021318
202095
201942
201841
20174
2016301
201521
201418
201321
201234
201132

How many Dechra patents are Alive/Dead?

Dechra Patents Portfolio

How Many Patents did Dechra File in Different Countries?

Dechra Worldwide Patents

Countries in which Dechra Filed Patents

CountryPatent
United States Of America40
Europe13
Brazil10
Canada7
Japan6
Australia6
Mexico6
Netherlands6
Portugal5
Spain5
China4
India4
Denmark3
Poland3
Norway2
Slovenia2
Serbia2
Croatia2
Singapore2
Malaysia2
Germany2
Hungary2
Hong Kong (S.A.R.)1
New Zealand1
Israel1
Lithuania1
Italy1

Where are Research Centres of Dechra Patents Located?

Research Centres of Dechra Patents

10 Best Dechra Patents

US20050214349A1 is the most popular patent in the Dechra portfolio. It has received 79 citations so far from companies like Mars Incorporated, Kimberly-Clark Worldwide and Big Heart Pet.

Below is the list of 10 most cited patents of Dechra:

Publication NumberCitation Count
US20050214349A179
US20030235610A146
US20080124385A125
US6420425B123
US20040115247A122
US7025965B121
US6610276B220
EP2338493A118
US20080318918A116
WO2009064859A112

How many inventions of other companies were rejected due to Dechra patents?

The statistics below share strategic R&D insights. It tells the companies that were trying to protect inventions similar to Dechra invention. They couldn’t because Dechra had protected those before them.

Examiners at the USPTO referred 10 Dechra patents in 64 rejections (35 USC § 102 or 35 USC § 103 types).

The top citing companies in the Dechra patent portfolio are Pacira, Luoda Pharma and Colgate-Palmolive.

List of the Companies whose Patents were rejected citing Dechra –

CompanyNumber of Patent Applications that faced Rejection Citing Dechra PatentsNumber of Rejections (102 & 103)
Pacira514
Luoda Pharma22
Colgate-Palmolive13
Tfh Publications11
Procter & Gamble11
Crampsaway11
University Of Queensland12
Hill’S Pet Nutrition110
Arms Pharmaceutical12
Icf Srl11

What are Dechra key innovation segments?

What Technologies are Covered by Dechra?

The chart below distributes patents filed by Dechra in different countries on the basis of the technology protected in patents. It also represents the markets where Dechra thinks it’s important to protect particular technology inventions.

R&D Focus: How has Dechra search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by the Dechra?

Table of Content

Insights you may find interesting

Related Articles

Computime Patents – Insights & Stats (Updated 2024)

Computime has a total of 224 patents globally, out of which 115 have been granted. Of these 224 patents, more than 63% patents are active. The United States of America is where Computime has filed the maximum number of patents, followed by Europe (EPO) and Germany. Parallelly, United States of

Read More »

Was this article helpful?

Leave a Comment

Fill the form to get the details:

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.